Nanoparticle-Based Plasmonic Biosensor for the Unamplified Genomic Detection of Carbapenem-Resistant Bacteria
Diagnostics · 09.02.2023 · 13 (4) · 656
DOI: 10.3390/diagnostics13040656 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 09.02.2023. Verfasst von Oznur Caliskan-Aydogan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosystems and Agricultural Engineering, Michigan State University, East Lansing, MI 48824, USA. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Food and Agriculture, United States Department of Agriculture, Targeted Support Grant for Technology Development (TSGTD).
Abstract (Originalsprache)
Antimicrobial resistance (AMR) is a global public health issue, and the rise of carbapenem-resistant bacteria needs attention. While progress is being made in the rapid detection of resistant bacteria, affordability and simplicity of detection still need to be addressed. This paper presents a nanoparticle-based plasmonic biosensor for detecting the carbapenemase-producing bacteria, particularly the beta-lactam Klebsiella pneumoniae carbapenemase (blaKPC) gene. The biosensor used dextrin-coated gold nanoparticles (GNPs) and an oligonucleotide probe specific to blaKPC to detect the target DNA in the sample within 30 min. The GNP-based plasmonic biosensor was tested in 47 bacterial isolates: 14 KPC-producing target bacteria and 33 non-target bacteria. The stability of GNPs, confirmed by the maintenance of their red appearance, indicated the presence of target DNA due to probe-binding and GNP protection. The absence of target DNA was indicated by the agglomeration of GNPs, corresponding to a color change from red to blue or purple. The plasmonic detection was quantified with absorbance spectra measurements. The biosensor successfully detected and differentiated the target from non-target samples with a detection limit of 2.5 ng/μL, equivalent to ~103 CFU/mL. The diagnostic sensitivity and specificity were found to be 79% and 97%, respectively. The GNP plasmonic biosensor is simple, rapid, and cost-effective in detecting blaKPC-positive bacteria.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biosystems and Agricultural Engineering, Michigan State University, East Lansing, MI 48824, USA.
- Global Alliance for Rapid Diagnostics, Michigan State University, East Lansing, MI 48824, USA.
Förderung
- National Institute of Food and Agriculture
- United States Department of Agriculture
- Targeted Support Grant for Technology Development (TSGTD)
- Michigan State University Foundation
- USDA National Institute of Food and Agriculture
- USDA-NIFA project
Zitieren
APA
Caliskan-Aydogan, O., Sharief, S. A., & Alocilja, E. C. (2023). Nanoparticle-Based Plasmonic Biosensor for the Unamplified Genomic Detection of Carbapenem-Resistant Bacteria. Diagnostics, 13(4), 656. https://doi.org/10.3390/diagnostics13040656
Vancouver
Caliskan-Aydogan O, Sharief SA, Alocilja EC. Nanoparticle-Based Plasmonic Biosensor for the Unamplified Genomic Detection of Carbapenem-Resistant Bacteria. Diagnostics. 2023;13(4):656. doi:10.3390/diagnostics13040656
BibTeX
@article{CaliskanAydogan2023,
author = {Caliskan-Aydogan, Oznur and Sharief, Saad Asadullah and Alocilja, Evangelyn C},
title = {Nanoparticle-Based Plasmonic Biosensor for the Unamplified Genomic Detection of Carbapenem-Resistant Bacteria},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {4},
pages = {656},
doi = {10.3390/diagnostics13040656}
}
EUVIMED